vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and QMMM Holdings Ltd (QMMM). Click either name above to swap in a different company.
QMMM Holdings Ltd is the larger business by last-quarter revenue ($2.0M vs $1.1M, roughly 1.8× Insight Molecular Diagnostics Inc.). QMMM Holdings Ltd runs the higher net margin — -7.1% vs -2015.4%, a 2008.2% gap on every dollar of revenue.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IMDX vs QMMM — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1M | $2.0M |
| Net Profit | $-23.0M | $-146.1K |
| Gross Margin | 42.5% | 27.1% |
| Operating Margin | -2057.5% | -6.5% |
| Net Margin | -2015.4% | -7.1% |
| Revenue YoY | -23.4% | — |
| Net Profit YoY | 31.5% | — |
| EPS (diluted) | $-0.75 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1M | — | ||
| Q3 25 | $260.0K | — | ||
| Q2 25 | $518.0K | — | ||
| Q1 25 | $2.1M | $2.0M | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $115.0K | — | ||
| Q2 24 | $104.0K | — | ||
| Q1 24 | $176.0K | $1.3M |
| Q4 25 | $-23.0M | — | ||
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $-9.7M | — | ||
| Q1 25 | $-6.7M | $-146.1K | ||
| Q4 24 | $-33.5M | — | ||
| Q3 24 | $-13.5M | — | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-9.1M | $-612.0K |
| Q4 25 | 42.5% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 67.6% | — | ||
| Q1 25 | 62.0% | 27.1% | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 43.5% | — | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 25.6% | 24.1% |
| Q4 25 | -2057.5% | — | ||
| Q3 25 | -4249.2% | — | ||
| Q2 25 | -1900.0% | — | ||
| Q1 25 | -318.0% | -6.5% | ||
| Q4 24 | -2262.9% | — | ||
| Q3 24 | -11752.2% | — | ||
| Q2 24 | -4453.8% | — | ||
| Q1 24 | -5265.3% | -46.2% |
| Q4 25 | -2015.4% | — | ||
| Q3 25 | -4174.6% | — | ||
| Q2 25 | -1880.7% | — | ||
| Q1 25 | -312.0% | -7.1% | ||
| Q4 24 | -2255.1% | — | ||
| Q3 24 | -11733.0% | — | ||
| Q2 24 | -4355.8% | — | ||
| Q1 24 | -5186.9% | -45.5% |
| Q4 25 | $-0.75 | — | ||
| Q3 25 | $-0.34 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.26 | — | ||
| Q4 24 | $-2.19 | — | ||
| Q3 24 | $-0.98 | — | ||
| Q2 24 | $-0.36 | — | ||
| Q1 24 | $-1.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $167.9K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-31.5M | $3.9M |
| Total Assets | $25.8M | $4.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | — | ||
| Q2 25 | $24.3M | — | ||
| Q1 25 | $31.0M | $167.9K | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | — | ||
| Q1 24 | $5.6M | $218.9K |
| Q4 25 | $-31.5M | — | ||
| Q3 25 | $-9.2M | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $10.2M | $3.9M | ||
| Q4 24 | $-12.3M | — | ||
| Q3 24 | $9.7M | — | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $11.6M | $-1.1M |
| Q4 25 | $25.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $50.5M | — | ||
| Q1 25 | $60.4M | $4.5M | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $70.2M | — | ||
| Q2 24 | $74.7M | — | ||
| Q1 24 | $71.0M | $1.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-301.2K |
| Free Cash FlowOCF − Capex | $-7.0M | — |
| FCF MarginFCF / Revenue | -616.7% | — |
| Capex IntensityCapex / Revenue | 129.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | — | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $-6.3M | — | ||
| Q1 25 | $-5.9M | $-301.2K | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $-5.5M | — | ||
| Q2 24 | $-6.0M | — | ||
| Q1 24 | $-3.8M | $-184.6K |
| Q4 25 | $-7.0M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | — | ||
| Q2 24 | $-6.2M | — | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | -616.7% | — | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | — | ||
| Q2 24 | -5931.7% | — | ||
| Q1 24 | -2189.8% | — |
| Q4 25 | 129.9% | — | ||
| Q3 25 | 403.8% | — | ||
| Q2 25 | 67.4% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | — | ||
| Q2 24 | 183.7% | — | ||
| Q1 24 | 13.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
